Toxicology studies in support of the UK CF Gene Therapy Consortium's Multi-dose Clinical Trial

U. Griesenbach; G. McLachlan; D. D. Collie; J. A. Innes; T. E. Higgins; S. H. Cheng; R. K. Scheule; E. W. F. W. Alton; J. C. Davies; S. C. Hyde; D. R. Gill; D. J. Porteous; Christopher Boyd

Toxicology studies in support of the UK CF Gene Therapy Consortium's Multi-dose Clinical Trial

U. Griesenbach, G. McLachlan, D. D. Collie, J. A. Innes, T. E. Higgins, S. H. Cheng, R. K. Scheule, E. W. F. W. Alton, J. C. Davies, S. C. Hyde, D. R. Gill, D. J. Porteous, Christopher Boyd

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	Undefined/Unknown
Pages (from-to)	A12-A12
Journal	Human Gene Therapy
Volume	23
Issue number	5
Publication status	Published - 2012
Event	Annual Conference of the British Society for Gene Therapy (BSGT) - London, United Kingdom Duration: 9 Mar 2012 → 9 Mar 2012

Access to Document

http://online.liebertpub.com/toc/hum/23/5

1 Finished

UK CF Gene Therapy Consortium Grant Funding
McLachlan, G., Boyd, C., Collie, D., Cunningham, S., Greening, A., Innes, A., Ogilvie, V. & Porteous, D.
UK-based charities
1/04/10 → 30/07/12
Project: Research

1 Abstract
1 Article

Preclinical Evaluation of Gene Therapy for Cystic Fibrosis in the Sheep Lung
McLachlan, G., 2012.
Research output: Contribution to conference › Abstract
Validation of recombinant Sendai virus in a non-natural host model
Griesenbach, U., McLachlan, G., Owaki, T., Somerton, L., Shu, T., Baker, A., Tennant, P., Gordon, C., Vrettou, C., Baker, E., Collie, D. D. S., Hasegawa, M. & Alton, E. W. F. W., Feb 2011, In: Gene Therapy. 18, 2, p. 182-188 7 p.
Research output: Contribution to journal › Article › peer-review

Cite this

Griesenbach, U., McLachlan, G., Collie, D. D., Innes, J. A., Higgins, T. E., Cheng, S. H., Scheule, R. K., Alton, E. W. F. W., Davies, J. C., Hyde, S. C., Gill, D. R., Porteous, D. J., & Boyd, C. (2012). Toxicology studies in support of the UK CF Gene Therapy Consortium's Multi-dose Clinical Trial. Human Gene Therapy, 23(5), A12-A12. http://online.liebertpub.com/toc/hum/23/5

@article{46a8de146eaf4899bfc40ab6c5e6f158,

title = "Toxicology studies in support of the UK CF Gene Therapy Consortium's Multi-dose Clinical Trial",

author = "U. Griesenbach and G. McLachlan and Collie, {D. D.} and Innes, {J. A.} and Higgins, {T. E.} and Cheng, {S. H.} and Scheule, {R. K.} and Alton, {E. W. F. W.} and Davies, {J. C.} and Hyde, {S. C.} and Gill, {D. R.} and Porteous, {D. J.} and Christopher Boyd",

note = "Times Cited: 0 Annual Conference of the British-Society-for-Gene-Therapy (BSGT) Mar09, 2012 UCL Inst Child Hlth, London, ENGLAND British Soc Gene Therapy (BSGT); Annual Conference of the British Society for Gene Therapy (BSGT) ; Conference date: 09-03-2012 Through 09-03-2012",

year = "2012",

language = "Undefined/Unknown",

volume = "23",

pages = "A12--A12",

journal = "Human Gene Therapy",

issn = "1043-0342",

publisher = "Mary Ann Liebert Inc.",

number = "5",

}

TY - JOUR

T1 - Toxicology studies in support of the UK CF Gene Therapy Consortium's Multi-dose Clinical Trial

AU - Griesenbach, U.

AU - McLachlan, G.

AU - Collie, D. D.

AU - Innes, J. A.

AU - Higgins, T. E.

AU - Cheng, S. H.

AU - Scheule, R. K.

AU - Alton, E. W. F. W.

AU - Davies, J. C.

AU - Hyde, S. C.

AU - Gill, D. R.

AU - Porteous, D. J.

AU - Boyd, Christopher

N1 - Times Cited: 0 Annual Conference of the British-Society-for-Gene-Therapy (BSGT) Mar09, 2012 UCL Inst Child Hlth, London, ENGLAND British Soc Gene Therapy (BSGT)

PY - 2012

Y1 - 2012

M3 - Meeting abstract

SN - 1043-0342

VL - 23

SP - A12-A12

JO - Human Gene Therapy

JF - Human Gene Therapy

IS - 5

T2 - Annual Conference of the British Society for Gene Therapy (BSGT)

Y2 - 9 March 2012 through 9 March 2012

ER -

Toxicology studies in support of the UK CF Gene Therapy Consortium's Multi-dose Clinical Trial

Access to Document

Projects

UK CF Gene Therapy Consortium Grant Funding

Research output

Preclinical Evaluation of Gene Therapy for Cystic Fibrosis in the Sheep Lung

Validation of recombinant Sendai virus in a non-natural host model

Cite this